Cue Biopharma (CUE) Revenue (2018 - 2025)

Cue Biopharma's Revenue history runs 8 years deep, the most recent figure standing at $9.5 million for Q4 2025.

• In Q4 2025, Revenue rose 502.79% year-over-year to $9.5 million; the TTM figure through Dec 2025 stood at $15.0 million (up 61.77% YoY), while the FY2025 annual figure was $27.5 million, up 195.75% from the prior year.
• Revenue came in at $9.5 million for Q4 2025 at Cue Biopharma, up from $2.1 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $9.5 million in Q4 2025 to a low of $26000.0 in Q2 2022.
• A 5-year average of $2.3 million and a median of $1.8 million in 2023 frame the typical range for Revenue.
• Across the five-year window, Revenue plunged 99.05% in 2022 and soared 5215.38% in 2023, its largest moves.
• Cue Biopharma's Revenue stood at $8.3 million in 2021, then sank by 98.17% to $151000.0 in 2022, then soared by 1105.96% to $1.8 million in 2023, then declined by 13.45% to $1.6 million in 2024, then soared by 502.79% to $9.5 million in 2025.
• According to Business Quant data, Revenue over the past three periods registered $9.5 million, $2.1 million, and $3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison